| I. Background | |
糖皮質激素誘導的腫瘤壞死因子受體相關蛋白（GITR，也稱為 TNFRSF18 或 CD357），屬于腫瘤壞死因子受體超家族（TNFRSF），它在多種免疫細胞上表達，包括 效應 T 細胞和調節性 T 細胞。GITR 在調節免疫系統中發揮重要作用，尤其是在 T 細胞的 活化和調節性 T 細胞（Treg）的功能中。 | |
| II. Description | |
| GITR NFκB-Luc Jurkat 報告基因藥靶模型很好的模擬了體內 GITR 的信號轉導過程， 原理見下圖所示。
Figure 1. GITR NFκB-Luc Jurkat 細胞模型原理圖 | |
| III. Introduction | |
| Host Cell: | Jurkat |
| Expressed gene: | GITR-NFκB-Luciferase |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+1 μg/ml Puromycin+400 μg/ml Hygromycin B |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Description of Host Cell Line | |
| Organism: | Human |
| Tissue: | Peripheral blood |
| Disease: | Childhood T acute lymphoblastic leukemia |
| Morphology: | Lymphoblast |
| Growth Properties: | Suspension |
| Ⅴ. Representative Data | |
Figure 2. Recombinant Jurkat stably expressing human GITR.
Figure 3. Detect Luciferase assay by Ultra Luciferase Detection Kit CBPH0001（we strongly suggest to purchase from Cobioer). Dose Response of Recombinant Human TNFSF18 in GITR-NFκB-Luc Jurkat(C1) Dose Response of GITR NFκB-Luc Jurkat(C1) Stimulated by GITRL CHO (C1).
" _ue_custom_node_="true">
化工儀器網